Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial. (linkinghub.elsevier.com)

Authors: Sun HC … Fan J Journal: The Lancet Published: 2026-08-22 DOI: https://doi.org/10.1016/S0140-6736(26)01252-3